Bio-Thera Solutions, Ltd. (SHA:688177)
China · Delayed Price · Currency is CNY 20.21
-0.14 (-0.69%)
At close: May 12, 2026
Bio-Thera Solutions Market Cap
Bio-Thera Solutions has a market cap or net worth of 8.37 billion as of May 12, 2026. Its market cap has decreased by -4.80% in one year.
Market Cap
8.37B
Enterprise Value
8.90B
Revenue
980.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.21
Market Cap Chart
Since February 21, 2020, Bio-Thera Solutions's market cap has decreased from 24.93B to 8.37B, a decrease of -66.43%. That is a compound annual growth rate of -16.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 8.37B | -12.66% |
| Dec 31, 2025 | 9.58B | 19.40% |
| Dec 31, 2024 | 8.02B | -53.01% |
| Dec 29, 2023 | 17.08B | 89.35% |
| Dec 30, 2022 | 9.02B | -15.68% |
| Dec 31, 2021 | 10.70B | -18.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daan Gene | 9.32B |
| Aurisco Pharmaceutical | 9.23B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.94B |
| Sino Biological,Inc. | 8.78B |
| GemPharmatech | 8.40B |
| Zhejiang Ausun Pharmaceutical | 8.38B |
| Nanjing Vazyme Biotech | 8.10B |
| Shanghai Medicilon | 8.06B |